BUZZ-Tilray Brands jumps after Q2 results
Reuters01-09
BUZZ-Tilray Brands jumps after <a href="https://laohu8.com/S/QTWO">Q2</a> results ** U.S.-listed shares of Canadian cannabis firm Tilray Brands TLRY.O up 8.9% at $9.95 premarket
** Co posts Q2 net revenue of $217.5 mln, up 3% from $211 mln a year earlier and in line with analyst estimates of $217.51 mln - data compiled by LSEG
** Adj. net loss narrows to $1.9 mln vs. $2.2 mln a year earlier
** TLRY sees U.S. federal rescheduling as key for medical cannabis; plans to leverage $150 mln global medical cannabis business and $300 mln pharma platform for expansion
** As of last close, TLRY stock down 33.3% over the past year
(Reporting by Tharuniyaa Lakshmi in Bengaluru)
((tharuniyaa@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
